<DOC>
	<DOCNO>NCT02501148</DOCNO>
	<brief_summary>The purpose study assess safety clinical performance Paladin System patient carotid artery stenosis .</brief_summary>
	<brief_title>A Multi-Center Study Evaluate Acute Safety Clinical Performance Paladin® Carotid Post-Dilation Balloon System With Integrated Embolic Protection</brief_title>
	<detailed_description />
	<mesh_term>Carotid Stenosis</mesh_term>
	<criteria>Documented stenotic atherosclerotic lesion locate carotid bifurcation / proximal internal carotid artery ( ICA ) Subject either ( A ) symptomatic within 6 month procedure , ipsilateral carotid stenosis ≥ 50 % angiography , ( B ) asymptomatic carotid stenosis ≥ 70 % angiography Target lesion cover single stent 40 mm length Target lesion reference vessel diameter ( RVD ) 4.0 mm 7.0mm Sufficient land zone require successful deployment integrate embolic protection filter Willing comply followup require study visit Provision write informed consent index procedure Life expectancy less one year An evolving , acute recent stroke within 14 day study evaluation Acute myocardial infarction within 72 hour procedure Known sensitivity contrast medium adequately control premedication Subject total occlusion target carotid artery Subject previously place stent ipsilateral carotid artery Severe circumferential lesion calcification may restrict full deployment carotid stent Presence filling defect thrombus target vessel Presence `` string sign '' target vessel Carotid ( intracranial ) stenosis locate distal target lesion Greater 50 % stenosis common carotid artery proximal target lesion . Known mobile plaque aortic arch</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Embolic protection</keyword>
	<keyword>Carotid artery stenting</keyword>
</DOC>